ZYME: Zymeworks Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Zymeworks Inc (ZYME).

OverviewDividends

$1.01B Market Cap.

As of 05/09/2025 5:00 PM ET (MRY) • Disclaimer

ZYME Market Cap. (MRY)


ZYME Shares Outstanding (MRY)


ZYME Assets (MRY)


Total Assets

$463.09M

Total Liabilities

$124.32M

Total Investments

$258.10M

ZYME Income (MRY)


Revenue

$76.30M

Net Income

-$122.69M

Operating Expense

$213.41M

ZYME Cash Flow (MRY)


CF Operations

-$110.04M

CF Investing

$38.76M

CF Financing

-$20.45M

ZYME Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$463,091,000 (-20.28%)

$580,880,000 (-10.46%)

$648,725,000 (66.71%)

$389,132,000 (-27.72%)

Assets Current

$300,451,000 (-27.24%)

$412,926,000 (-24.19%)

$544,706,000 (88.99%)

$288,220,000 (-36.67%)

Assets Non-Current

$162,640,000 (-3.16%)

$167,954,000 (61.46%)

$104,019,000 (3.08%)

$100,912,000 (21.14%)

Goodwill & Intangible Assets

$16,592,000 (-15.66%)

$19,672,000 (-5.29%)

$20,771,000 (31.01%)

$15,854,000 (-8.46%)

Shareholders Equity

$338,768,000 (-27.12%)

$464,806,000 (-5.71%)

$492,956,000 (97.90%)

$249,094,000 (-39.23%)

Property Plant & Equipment Net

$34,316,000 (-8.60%)

$37,543,000 (-21.21%)

$47,650,000 (-4.26%)

$49,770,000 (182.56%)

Cash & Equivalents

$66,103,000 (-58.05%)

$157,557,000 (-60.70%)

$400,912,000 (98.60%)

$201,867,000 (-16.60%)

Accumulated Other Comprehensive Income

-$6,952,000 (-5.29%)

-$6,603,000 (0.84%)

-$6,659,000 (0.00%)

-$6,659,000 (0.00%)

Deferred Revenue

$40,195,000 (9.70%)

$36,640,000 (11.23%)

$32,941,000 (0.00%)

$32,941,000 (0.00%)

Total Investments

$258,101,000 (-13.59%)

$298,700,000 (223.95%)

$92,206,000 (78.60%)

$51,627,000 (-75.44%)

Investments Current

$159,673,000 (-26.34%)

$216,770,000 (137.37%)

$91,320,000 (79.97%)

$50,741,000 (-72.47%)

Investments Non-Current

$98,428,000 (20.14%)

$81,930,000 (9147.18%)

$886,000 (0.00%)

$886,000 (-96.58%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$55,815,000 (186.57%)

$19,477,000 (-41.69%)

$33,400,000 (113.91%)

$15,614,000 (2.10%)

Trade & Non-Trade Payables

$59,838,000 (30.11%)

$45,992,000 (-47.42%)

$87,468,000 (39.30%)

$62,789,000 (43.83%)

Accumulated Retained Earnings (Deficit)

-$830,335,000 (-22.57%)

-$677,437,000 (-21.24%)

-$558,763,000 (18.20%)

-$683,104,000 (-44.95%)

Tax Assets

$4,385,000 (21.30%)

$3,615,000 (168.77%)

$1,345,000 (-56.19%)

$3,070,000 (78.18%)

Tax Liabilities

$4,889,000 (169.96%)

$1,811,000 (115.60%)

$840,000 (0%)

$0 (0%)

Total Debt

$18,478,000 (-30.61%)

$26,630,000 (-4.86%)

$27,989,000 (-13.17%)

$32,233,000 (278.23%)

Debt Current

$2,740,000 (-35.70%)

$4,261,000 (28.27%)

$3,322,000 (153.59%)

$1,310,000 (-51.66%)

Debt Non-Current

$15,738,000 (-29.64%)

$22,369,000 (-9.32%)

$24,667,000 (-20.23%)

$30,923,000 (432.05%)

Total Liabilities

$124,323,000 (7.11%)

$116,074,000 (-25.48%)

$155,769,000 (11.23%)

$140,038,000 (9.02%)

Liabilities Current

$88,294,000 (58.34%)

$55,763,000 (-41.69%)

$95,625,000 (33.08%)

$71,853,000 (-16.12%)

Liabilities Non-Current

$36,029,000 (-40.26%)

$60,311,000 (0.28%)

$60,144,000 (-11.79%)

$68,185,000 (59.36%)

ZYME Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$76,304,000 (0.38%)

$76,012,000 (-81.57%)

$412,482,000 (1446.03%)

$26,680,000 (-31.50%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$61,506,000 (-12.69%)

$70,446,000 (-3.97%)

$73,358,000 (72.36%)

$42,561,000 (-22.92%)

Research & Development Expense

$134,621,000 (-6.27%)

$143,619,000 (-31.15%)

$208,596,000 (4.43%)

$199,752,000 (16.68%)

Operating Expenses

$213,414,000 (-0.30%)

$214,065,000 (-24.08%)

$281,954,000 (16.36%)

$242,313,000 (7.02%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$6,084,000 (1171.13%)

-$568,000 (-105.21%)

$10,893,000 (2211.05%)

-$516,000 (-220.28%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$122,695,000 (-3.39%)

-$118,674,000 (-195.44%)

$124,341,000 (158.69%)

-$211,843,000 (-17.33%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$122,695,000 (-3.39%)

-$118,674,000 (-195.44%)

$124,341,000 (158.69%)

-$211,843,000 (-17.33%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$122,695,000 (-3.39%)

-$118,674,000 (-195.44%)

$124,341,000 (158.69%)

-$211,843,000 (-17.33%)

Weighted Average Shares

$75,846,681 (10.14%)

$68,863,010 (5.63%)

$65,194,775 (26.46%)

$51,553,869 (2.32%)

Weighted Average Shares Diluted

$75,878,738 (10.19%)

$68,863,010 (5.54%)

$65,249,184 (25.16%)

$52,131,596 (3.47%)

Earning Before Interest & Taxes (EBIT)

-$116,611,000 (2.21%)

-$119,242,000 (-188.17%)

$135,234,000 (163.68%)

-$212,359,000 (-17.90%)

Gross Profit

$76,304,000 (0.38%)

$76,012,000 (-81.57%)

$412,482,000 (1446.03%)

$26,680,000 (-31.50%)

Operating Income

-$137,110,000 (0.68%)

-$138,053,000 (-205.77%)

$130,528,000 (160.53%)

-$215,633,000 (-15.02%)

ZYME Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$38,756,000 (118.70%)

-$207,253,000 (-284.88%)

-$53,849,000 (-137.24%)

$144,596,000 (432.86%)

Net Cash Flow from Financing

-$20,452,000 (-124.99%)

$81,847,000 (-24.62%)

$108,582,000 (1255.41%)

$8,011,000 (-97.41%)

Net Cash Flow from Operations

-$110,044,000 (6.98%)

-$118,303,000 (-182.09%)

$144,109,000 (174.88%)

-$192,451,000 (-27.11%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$91,454,000 (62.42%)

-$243,355,000 (-222.26%)

$199,045,000 (595.52%)

-$40,169,000 (-135.36%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$41,822,000 (120.58%)

-$203,176,000 (-398.91%)

-$40,724,000 (-125.79%)

$157,881,000 (524.70%)

Capital Expenditure

-$1,991,000 (19.52%)

-$2,474,000 (69.64%)

-$8,150,000 (34.30%)

-$12,404,000 (-187.80%)

Issuance (Repayment) of Debt Securities

-$14,000 (33.33%)

-$21,000 (-50.00%)

-$14,000 (17.65%)

-$17,000 (58.54%)

Issuance (Purchase) of Equity Shares

-$20,264,000 (-124.74%)

$81,921,000 (-24.98%)

$109,192,000 (1184.91%)

$8,498,000 (-97.25%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$286,000 (-19.21%)

$354,000 (74.38%)

$203,000 (162.46%)

-$325,000 (40.91%)

Share Based Compensation

$17,792,000 (119.60%)

$8,102,000 (101.79%)

$4,015,000 (-62.67%)

$10,756,000 (-63.06%)

Depreciation Amortization & Accretion

$11,193,000 (-35.32%)

$17,305,000 (44.16%)

$12,004,000 (25.26%)

$9,583,000 (-6.77%)

ZYME Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-160.80% (-3.01%)

-156.10% (-618.60%)

30.10% (103.79%)

-794.00% (-71.31%)

EBITDA Margin

-138.20% (-3.06%)

-134.10% (-475.63%)

35.70% (104.70%)

-760.00% (-74.31%)

Return on Average Equity (ROAE)

-31.70% (-20.99%)

-26.20% (-162.09%)

42.20% (161.07%)

-69.10% (-77.63%)

Return on Average Assets (ROAA)

-24.30% (-19.70%)

-20.30% (-171.23%)

28.50% (159.62%)

-47.80% (-55.70%)

Return on Sales (ROS)

-152.80% (2.61%)

-156.90% (-578.35%)

32.80% (104.12%)

-795.90% (-72.12%)

Return on Invested Capital (ROIC)

-34.00% (-7.26%)

-31.70% (-129.79%)

106.40% (165.00%)

-163.70% (-147.66%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-9.04 (-49.59%)

-6.04 (-246.80%)

4.12 (203.18%)

-3.99 (69.79%)

Price to Sales Ratio (P/S)

14.55 (54.59%)

9.41 (657.89%)

1.24 (-96.08%)

31.67 (-48.19%)

Price to Book Ratio (P/B)

2.98 (90.22%)

1.56 (55.88%)

1 (-67.22%)

3.06 (-42.03%)

Debt to Equity Ratio (D/E)

0.37 (46.80%)

0.25 (-20.89%)

0.32 (-43.77%)

0.56 (79.55%)

Earnings Per Share (EPS)

-1.62 (5.81%)

-1.72 (-190.05%)

1.91 (146.47%)

-4.11 (-14.80%)

Sales Per Share (SPS)

1.01 (-8.88%)

1.1 (-82.55%)

6.33 (1121.43%)

0.52 (-32.99%)

Free Cash Flow Per Share (FCFPS)

-1.48 (15.79%)

-1.75 (-184.12%)

2.08 (152.47%)

-3.97 (-28.57%)

Book Value Per Share (BVPS)

4.47 (-33.84%)

6.75 (-10.73%)

7.56 (56.48%)

4.83 (-40.61%)

Tangible Assets Book Value Per Share (TABVPS)

5.89 (-27.77%)

8.15 (-15.39%)

9.63 (33.02%)

7.24 (-29.98%)

Enterprise Value Over EBIT (EV/EBIT)

-8 (-33.33%)

-6 (-300.00%)

3 (200.00%)

-3 (72.73%)

Enterprise Value Over EBITDA (EV/EBITDA)

-8.6 (-32.94%)

-6.47 (-321.93%)

2.91 (209.51%)

-2.66 (76.58%)

Asset Turnover

0.15 (16.15%)

0.13 (-86.23%)

0.94 (1473.33%)

0.06 (-9.09%)

Current Ratio

3.4 (-54.04%)

7.41 (30.00%)

5.7 (42.01%)

4.01 (-24.49%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$112,035,000 (7.24%)

-$120,777,000 (-188.83%)

$135,959,000 (166.37%)

-$204,855,000 (-31.56%)

Enterprise Value (EV)

$906,227,981 (37.47%)

$659,237,645 (53.67%)

$429,008,028 (-20.50%)

$539,645,470 (-72.03%)

Earnings Before Tax (EBT)

-$116,611,000 (2.21%)

-$119,242,000 (-188.17%)

$135,234,000 (163.68%)

-$212,359,000 (-17.90%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$105,418,000 (-3.41%)

-$101,937,000 (-169.23%)

$147,238,000 (172.61%)

-$202,776,000 (-19.39%)

Invested Capital

$310,580,000 (-17.07%)

$374,518,000 (134.95%)

$159,406,000 (20.95%)

$131,791,000 (-34.72%)

Working Capital

$212,157,000 (-40.60%)

$357,163,000 (-20.47%)

$449,081,000 (107.56%)

$216,367,000 (-41.43%)

Tangible Asset Value

$446,499,000 (-20.44%)

$561,208,000 (-10.63%)

$627,954,000 (68.23%)

$373,278,000 (-28.36%)

Market Capitalization

$1,008,366,981 (38.64%)

$727,320,645 (46.89%)

$495,151,028 (-35.11%)

$763,019,470 (-64.77%)

Average Equity

$387,476,500 (-14.45%)

$452,901,750 (53.86%)

$294,360,000 (-4.01%)

$306,660,000 (-33.91%)

Average Assets

$504,907,250 (-13.69%)

$585,010,750 (33.87%)

$436,983,250 (-1.33%)

$442,876,250 (-24.73%)

Invested Capital Average

$342,965,500 (-8.73%)

$375,758,000 (195.60%)

$127,118,000 (-2.01%)

$129,719,250 (-52.43%)

Shares

68,877,526 (-1.61%)

70,001,987 (11.12%)

62,996,314 (35.32%)

46,553,964 (1.58%)